Navigation Links
Cryolife Once Again Severely Maims an Innocent Knee Surgery Patient

$110,000,000.00 lawsuit filed 11 Dec. 2008

ATLANTA, Jan. 11 /PRNewswire-USNewswire/ -- Cryolife, Inc., (NYSE: CRY) the country's largest distributor of cadaver tissue has once again severely maimed an elective knee surgery patient, Michael Hohenbery, with a contaminated infected knee tissue implant. Shockingly the same deadly organism that devastated Mr. Hohenbery took the life of young Brian Lykins of Minnesota in 2001.

The Lykins' death, another of the Keenan Law Firm's clients, first alerted the nation of the unregulated cadaver tissue billion dollar industry. Brian's death led the FDA shutdown in 2002 of Cryolife's tissue business and the passage of 900 plus pages of safety regulations which at the time of passage were insufficient and created large loopholes.

The FDA eventually after a year in mid 2003 permitted Cryolife to resume distribution of cadaver tissue but yet less than 30 days later a teenager from Denver was catastrophically infected by diseased knee cadaver tissue. Over the years many lawsuits have been prosecuted across the United Stated, Europe, and other countries concerning unsafe cadaver processing practices.

The recent victim Michael Hohenbery a farm equipment mechanic from downstate Illinois can no longer work and will be on mega antibiotics and pain medications the rest of his life. His suit will be filed Friday in Cobb County the location of Cryolife.

The Hohenbery case once again proves the unsafe and dangerous practices of Cryolife and the ineffectiveness of the safety regulations. While all states require licensure, testing and health certificates for barbers, nail salon technicians, and masseuses, there are no regulations regarding the qualifications of anyone handling and processing cadaver tissue.

"With over one million operations a year using cadaver tissues, how many more people will die or be seriously injured from dangerous unsafe practices of Cryolife. This travesty must stop," said Don Keenan attorney for Michael Hohenbery.

Don Keenan is available for comment 24/7.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CryoLife Names Philip Theodore as Vice President, General Counsel
2. CryoLife to Present at Bear Stearns Healthcare and First Albany Capitals Regenerative Technologies Conferences in New York
3. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
4. CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million
5. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
6. CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York
7. CryoLife to Present at OneMedPlace Finance Forum
8. CryoLife Announces Record Preservation Services and Product Revenues for 2007
9. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
10. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
11. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
Post Your Comments:
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
Breaking Biology News(10 mins):